Charlotte P. De Jonge

Maastricht, LI, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Breast conserving surgery with intraoperative electron beam radiation therapy for low-risk breast cancer: Five-year follow-up of 306 patients.

Breast conserving surgery with intraoperative electron beam radiation therapy for low-risk breast cancer: Five-year follow-up of 306 patients.

Journal: International journal of cancer
Published: December 10, 2023

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.

Endoscopic Duodenal-Jejunal Bypass Liner Treatment for Type 2 Diabetes and Obesity: Glycemic and Cardiovascular Disease Risk Factor Improvements in 1,022 Patients Treated Worldwide.

Journal: Diabetes care
Published: October 06, 2022

Additively manufactured space-filling meta-implants.

Additively manufactured space-filling meta-implants.

Journal: Acta biomaterialia
Published: November 13, 2020

Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical Trial.

Effect of the EndoBarrier Device: a 4-Year Follow-up of a Multicenter Randomized Clinical Trial.

Journal: Obesity surgery
Published: January 11, 2019

Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans.

Duodenal-jejunal lining increases postprandial unconjugated bile acid responses and disrupts the bile acid-FXR-FGF19 axis in humans.

Journal: Metabolism: clinical and experimental
Published: September 30, 2018

Metabolic improvement in obese patients after duodenal-jejunal exclusion is associated with intestinal microbiota composition changes.

Metabolic improvement in obese patients after duodenal-jejunal exclusion is associated with intestinal microbiota composition changes.

Journal: International journal of obesity (2005)
Published: August 15, 2018

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.

The Effect of 6 and 12 months Duodenal-Jejunal Bypass Liner Treatment on Obesity and Type 2 Diabetes: a Crossover Cohort Study.

Journal: Obesity surgery
Published: November 08, 2017

Impact of Duodenal-Jejunal Exclusion on Satiety Hormones.

Impact of Duodenal-Jejunal Exclusion on Satiety Hormones.

Journal: Obesity surgery
Published: October 09, 2015

The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.

The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial.

Journal: Annals of surgery
Published: July 30, 2014

Complement alternative pathway activation in human nonalcoholic steatohepatitis.

Complement alternative pathway activation in human nonalcoholic steatohepatitis.

Journal: PloS one
Published: June 04, 2014

Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes.

Six months of treatment with the endoscopic duodenal-jejunal bypass liner does not lead to decreased systemic inflammation in obese patients with type 2 diabetes.

Journal: Obesity surgery
Published: December 21, 2013

Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

Journal: Obesity surgery
Published: March 26, 2013
Showing 1-12 of 17

Last Updated: 09/26/2026